(Q53287077)

13 May 2018

title

Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population. (English)

1 reference

13 May 2018

author name string

Pengfei Shao

1

1 reference

13 May 2018

Qi Ding

2

1 reference

13 May 2018

Chao Qin

3

1 reference

13 May 2018

Meilin Wang

4

1 reference

13 May 2018

Jialin Tang

5

1 reference

13 May 2018

Jian Zhu

6

1 reference

13 May 2018

Jiawei Chen

7

1 reference

13 May 2018

Qiang Cao

8

1 reference

13 May 2018

Jie Li

9

1 reference

13 May 2018

Bin Xu

10

1 reference

13 May 2018

Zhengdong Zhang

11

1 reference

13 May 2018

Wei Zhang

12

1 reference

13 May 2018

Changjun Yin

13

1 reference

13 May 2018

publication date

12 January 2011

1 reference

13 May 2018

published in

The Prostate

1 reference

13 May 2018

volume

71

1 reference

13 May 2018

issue

10

1 reference

13 May 2018

page(s)

1122-1130

1 reference

13 May 2018

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Human prostate cancer risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Apoptosis in the pathogenesis and treatment of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

The Fas signalling pathway and its role in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Defining CD95 as a tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

2LD, GENECOUNTING and HAP: Computer programs for linkage disequilibrium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

A New Statistical Method for Haplotype Reconstruction from Population Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

A comparison of bayesian methods for haplotype reconstruction from population genotype data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Soluble Fas in the serum of patients with non-Hodgkin's lymphoma: higher concentrations in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Prognostic significance of soluble Fas in the serum of patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

Association between FAS polymorphism and prostate cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21328

21 January 2018

Identifiers

DOI

10.1002/PROS.21328

1 reference

13 May 2018

1 reference

13 May 2018